RESEARCH-USE BIOSIMILAR ANTIBODY
Caplacizumab
Antibody fragment · VH VH
Caplacizumab is a humanised antibody fragment reference material directed against VWF.
TARGETVWF
YAntibody fragment
CATALOGSC-BS-677
CATALOG NUMBERSC-BS-677
MOLECULAR WEIGHTApprox. 27.9 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Caplacizumab is a humanised antibody fragment reference material directed against VWF.
Caplacizumab is a recombinant research-use antibody directed against VWF.